Investment Summary

Amulet Capital Partners Invests In SSI Strategy

On December 21, 2020, private equity firm Amulet Capital Partners invested in business services company SSI Strategy

Investment Highlights
  • This is Amulet Capital Partners’ 2nd transaction in the Business Services sector.
  • This is Amulet Capital Partners’ 6th transaction in the United States.
  • This is Amulet Capital Partners’ 2nd transaction in New Jersey.

Investment Summary
Date 2020-12-21
Target SSI Strategy
Sector Business Services
Investor(s) Amulet Capital Partners
Deal Type Growth Capital
Advisor(s) Inverness Advisors (Financial)
Golenbock Eiseman Assor Bell & Peskoe (Legal)

Target

SSI Strategy

Parsippany, New Jersey, United States
SSI Strategy is a boutique management-consulting firm that has designed a unique model to support scientific functions within Life Science companies. SSI Strategy is based in Parsippany, New Jersey.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Amulet Capital Partners

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2013
Size Small
Type Sector Focused
DESCRIPTION

Amulet Capital Partners is a private investment firm focused on middle-market investments in the healthcare sector. Amulet looks to commit $25 to $150 million per transaction to a support a variety of transaction situations including, buyouts, corporate divestitures, growth capital financings, and special situations. Amulet Capital was established in 2013 and is headquartered in Greenwich, Connecticut.

DEAL STATS #
Overall 7 of 15
Sector (Business Services) 2 of 2
Type (Growth Capital) 2 of 5
State (New Jersey) 2 of 2
Country (United States) 6 of 14
Year (2020) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-29 Synteract

Carlsbad, California, United States

Synteract, Inc. is an operator of a full-service international contract research organization (CRO) focused on Phase I‐IV clinical trials for emerging to mid-sized biopharma clients in the U.S., Europe, and Asia. Synteract was founded in 1995 and is based in Carlsbad, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-27 Remedy Health Media

New York, New York, United States

Remedy Health Media is a digital health platform specializing in inspirational video-based storytelling and award-winning digital brands. The Company's portfolio of brands includes HealthCentral, TheBody, TheBodyPro, BerkeleyWellness, and Healthcommunities. Remedy Health Media was founded in 1994 and is based in New York City.

Buy -
Mergr

Product

Company

Legal